Pub Date : 2025-09-01Epub Date: 2025-08-06DOI: 10.5468/ogs.24334
Rania Gamal, Ahmed Zidan, Waleed Shawky, Joseph Ibrahim, Yassin Mostafa, Tarek Sabry, Amro Elhusseiny, Radwa Ali
Objective: Office hysteroscopy (OH) is widely used to diagnose and manage intrauterine pathologies. However, pain remains the primary factor that contributes to OH failure. This study aimed to assess the effect of virtual reality (VR) on pain reduction during OH.
Methods: A prospective randomized controlled clinical trial was conducted at a university hospital between July and November 2024. The study involved 50 women undergoing OH randomly allocated to receive immersive VR videos during the procedure or standard care. The main outcome measure was self-reported intraoperative pain evaluated using a numerical rating scale. Other measures included satisfaction, duration, and success of the procedure.
Results: Mean pain scores were 6.16±1.86 in standard care group and 4.88±1.69 in VR group (difference, 1.28; 95% confidence interval [CI], 0.27 to 2.29; P=0.014). After adjusting for other variables, no statistically significant relationship was found between VR and severe pain (odds ratio, 0.75; 95% CI, 0.15 to 3.87; P=0.73); only severe anxiety in women and procedure duration were associated with severe pain.
Conclusion: Virtual reality did not significantly reduce pain severity during hysteroscopy. However, severe pain was associated with high anxiety and a longer procedure duration. These findings suggest that VR may not effectively mitigate severe pain, whereas managing anxiety and minimizing procedure time could be more effective strategies.
{"title":"Virtual reality for pain relief during office hysteroscopy: a randomized controlled trial.","authors":"Rania Gamal, Ahmed Zidan, Waleed Shawky, Joseph Ibrahim, Yassin Mostafa, Tarek Sabry, Amro Elhusseiny, Radwa Ali","doi":"10.5468/ogs.24334","DOIUrl":"10.5468/ogs.24334","url":null,"abstract":"<p><strong>Objective: </strong>Office hysteroscopy (OH) is widely used to diagnose and manage intrauterine pathologies. However, pain remains the primary factor that contributes to OH failure. This study aimed to assess the effect of virtual reality (VR) on pain reduction during OH.</p><p><strong>Methods: </strong>A prospective randomized controlled clinical trial was conducted at a university hospital between July and November 2024. The study involved 50 women undergoing OH randomly allocated to receive immersive VR videos during the procedure or standard care. The main outcome measure was self-reported intraoperative pain evaluated using a numerical rating scale. Other measures included satisfaction, duration, and success of the procedure.</p><p><strong>Results: </strong>Mean pain scores were 6.16±1.86 in standard care group and 4.88±1.69 in VR group (difference, 1.28; 95% confidence interval [CI], 0.27 to 2.29; P=0.014). After adjusting for other variables, no statistically significant relationship was found between VR and severe pain (odds ratio, 0.75; 95% CI, 0.15 to 3.87; P=0.73); only severe anxiety in women and procedure duration were associated with severe pain.</p><p><strong>Conclusion: </strong>Virtual reality did not significantly reduce pain severity during hysteroscopy. However, severe pain was associated with high anxiety and a longer procedure duration. These findings suggest that VR may not effectively mitigate severe pain, whereas managing anxiety and minimizing procedure time could be more effective strategies.</p>","PeriodicalId":37602,"journal":{"name":"Obstetrics and Gynecology Science","volume":"68 5","pages":"424-432"},"PeriodicalIF":1.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12463480/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145151313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-08-05DOI: 10.5468/ogs.25088
Sopita Prasertpakdi, Prapaporn Suprasert
Objective: BReast CAncer (BRCA) gene mutations increase the risk of epithelial ovarian and fallopian tube cancers. Genetic counseling and screening play a crucial role in identifying individuals at risk. Assessing knowledge, attitudes, and practices (KAP) related to BRCA mutations among family members of affected individuals can assist in early detection and preventive strategies. This study aims to evaluate KAP among family members of patients with these cancers to identify gaps and improve awareness.
Methods: A cross-sectional survey was conducted between March and November 2024, involving 215 participants with a family history of epithelial ovarian or fallopian tube cancer. Data were collected through structured interviews.
Results: The mean age of participants was 47.3 years; 42.8% were single and 44.2% were nulliparous. Most participants (65.6%) had one affected relative, with 86.5% being first-degree relatives. Only 16.3% had heard of BRCA mutations and 18.2% were aware of their association with ovarian cancer. The most commonly recognized ovarian cancer symptom was abdominal swelling. The highest mean KAP score was associated with the belief that regular pelvic examinations should be performed. Multivariate analysis identified independent factors influencing the desire for BRCA screening, including an attitude score of ≥25 (adjusted odds ratio [AOR], 12.638; P<0.001), follow-up duration of >5 years (AOR, 2.504; P=0.016), and ongoing or ineffective treatment (AOR, 4.303; P<0.001).
Conclusion: Substantial gaps in KAP regarding BRCA mutations persist among family members of affected individuals. Targeted educational interventions and healthcare initiatives are essential to enhance awareness and support informed decision-making in high-risk populations.
{"title":"A knowledge, attitudes, and practices study on BRCA mutations among family members of women diagnosed with epithelial ovarian or fallopian tube cancer.","authors":"Sopita Prasertpakdi, Prapaporn Suprasert","doi":"10.5468/ogs.25088","DOIUrl":"10.5468/ogs.25088","url":null,"abstract":"<p><strong>Objective: </strong>BReast CAncer (BRCA) gene mutations increase the risk of epithelial ovarian and fallopian tube cancers. Genetic counseling and screening play a crucial role in identifying individuals at risk. Assessing knowledge, attitudes, and practices (KAP) related to BRCA mutations among family members of affected individuals can assist in early detection and preventive strategies. This study aims to evaluate KAP among family members of patients with these cancers to identify gaps and improve awareness.</p><p><strong>Methods: </strong>A cross-sectional survey was conducted between March and November 2024, involving 215 participants with a family history of epithelial ovarian or fallopian tube cancer. Data were collected through structured interviews.</p><p><strong>Results: </strong>The mean age of participants was 47.3 years; 42.8% were single and 44.2% were nulliparous. Most participants (65.6%) had one affected relative, with 86.5% being first-degree relatives. Only 16.3% had heard of BRCA mutations and 18.2% were aware of their association with ovarian cancer. The most commonly recognized ovarian cancer symptom was abdominal swelling. The highest mean KAP score was associated with the belief that regular pelvic examinations should be performed. Multivariate analysis identified independent factors influencing the desire for BRCA screening, including an attitude score of ≥25 (adjusted odds ratio [AOR], 12.638; P<0.001), follow-up duration of >5 years (AOR, 2.504; P=0.016), and ongoing or ineffective treatment (AOR, 4.303; P<0.001).</p><p><strong>Conclusion: </strong>Substantial gaps in KAP regarding BRCA mutations persist among family members of affected individuals. Targeted educational interventions and healthcare initiatives are essential to enhance awareness and support informed decision-making in high-risk populations.</p>","PeriodicalId":37602,"journal":{"name":"Obstetrics and Gynecology Science","volume":" ","pages":"390-400"},"PeriodicalIF":1.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12463482/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144785521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-05-29DOI: 10.5468/ogs.25041
Syed S Abrar, Seoparjoo Azmel Mohd Isa, Suhaily Mohd Hairon, Mohd Pazudin Ismail, Mohd Nasrullah Bin Nik Ab Kadir
Artificial intelligence (AI) and machine learning (ML) are transforming cervical cancer research and offering advancements in diagnosis, prognosis, screening, and treatment. This review explores ML applications with particular emphasis on prediction models. A comprehensive literature search identified studies using ML for survival prediction, risk assessment, and treatment optimization. ML-driven prognostic models integrate clinical, histopathological, and genomic data to improve survival prediction and patient stratification. Screening methods, including deep-learning-based cytology analysis and human papillomavirus detection, enhance accuracy and efficiency. ML-driven imaging techniques facilitate early and precise cancer diagnosis, while risk prediction models assess susceptibility based on demographic and genetic factors. AI also optimizes treatment planning by predicting therapeutic responses and guiding personalized interventions. Despite significant progress, challenges remain regarding data availability, model interpretability, and clinical implementation. Standardized datasets, external validation, and cross-disciplinary collaborations are crucial for implementing ML innovations in clinical settings. Subsequent investigations should prioritize joint initiatives among data scientists, healthcare providers, and health authorities to translate AI innovations into real-world applications and to enhance the impact of ML on cervical cancer care. By synthesizing recent developments, this review highlights the potential of ML to improve clinical outcomes and shaping the future of cervical cancer management.
{"title":"Recent advances in applications of machine learning in cervical cancer research: a focus on prediction models.","authors":"Syed S Abrar, Seoparjoo Azmel Mohd Isa, Suhaily Mohd Hairon, Mohd Pazudin Ismail, Mohd Nasrullah Bin Nik Ab Kadir","doi":"10.5468/ogs.25041","DOIUrl":"10.5468/ogs.25041","url":null,"abstract":"<p><p>Artificial intelligence (AI) and machine learning (ML) are transforming cervical cancer research and offering advancements in diagnosis, prognosis, screening, and treatment. This review explores ML applications with particular emphasis on prediction models. A comprehensive literature search identified studies using ML for survival prediction, risk assessment, and treatment optimization. ML-driven prognostic models integrate clinical, histopathological, and genomic data to improve survival prediction and patient stratification. Screening methods, including deep-learning-based cytology analysis and human papillomavirus detection, enhance accuracy and efficiency. ML-driven imaging techniques facilitate early and precise cancer diagnosis, while risk prediction models assess susceptibility based on demographic and genetic factors. AI also optimizes treatment planning by predicting therapeutic responses and guiding personalized interventions. Despite significant progress, challenges remain regarding data availability, model interpretability, and clinical implementation. Standardized datasets, external validation, and cross-disciplinary collaborations are crucial for implementing ML innovations in clinical settings. Subsequent investigations should prioritize joint initiatives among data scientists, healthcare providers, and health authorities to translate AI innovations into real-world applications and to enhance the impact of ML on cervical cancer care. By synthesizing recent developments, this review highlights the potential of ML to improve clinical outcomes and shaping the future of cervical cancer management.</p>","PeriodicalId":37602,"journal":{"name":"Obstetrics and Gynecology Science","volume":" ","pages":"247-259"},"PeriodicalIF":1.9,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12301556/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144180522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: Random blood glucose (rBG) levels are commonly measured in Japan; however, no standardized cutoff values exist for glucose tolerance screening in early pregnancy. The contribution of glycated hemoglobin (HbA1c) and glycated albumin (GA) measurements to the diagnosis of gestational diabetes mellitus (GDM) remains unclear. Therefore, we aimed to evaluate the significance of these glycemic indicators in early pregnancy for predicting GDM.
Methods: This observational cohort study enrolled pregnant women who underwent initial prenatal examinations to determine their rBG, HbA1c, and GA levels at a rural maternity facility. Clinical data were retrospectively reviewed.
Results: A total of 449 patients were analyzed, comprising 394 with normal glucose tolerance (NGT) and 55 with GDM. The rBG, HbA1c, and GA levels were significantly higher during early pregnancy in women who developed GDM than in those with NGT. Receiver operating characteristic curve analysis revealed that the areas under the curve (AUC) for rBG, HbA1c, and GA were 0.733, 0.591, and 0.608, respectively, with cutoff values of 100 mg/dL, 5.2%, and 14.6%, respectively. These cutoff values had sensitivities of 52.7%, 70.9%, and 36.4% and specificities of 87.6%, 43.4%, and 82.5%, respectively. The product of rBG and HbA1c levels demonstrated improved performance, with an AUC of 0.750, cutoff value of 509, 63.6% sensitivity, and 83.5% specificity.
Conclusion: Glucose tolerance screening in early pregnancy using an rBG level of 100 mg/dL and an HbA1c level of 5.2% as cutoff values may help identify high-risk cases and enable early diagnosis of GDM.
{"title":"Role of random blood glucose and HbA1c levels in optimizing glucose tolerance screening in early pregnancy: a retrospective cohort study.","authors":"Yoshitsugu Chigusa, Yoshikazu Ikeda, Akitoshi Yamamura, Haruta Mogami, Akiko Nishimura, Satoshi Morita, Masaki Mandai, Shin-Ichi Harashima","doi":"10.5468/ogs.25052","DOIUrl":"10.5468/ogs.25052","url":null,"abstract":"<p><strong>Objective: </strong>Random blood glucose (rBG) levels are commonly measured in Japan; however, no standardized cutoff values exist for glucose tolerance screening in early pregnancy. The contribution of glycated hemoglobin (HbA1c) and glycated albumin (GA) measurements to the diagnosis of gestational diabetes mellitus (GDM) remains unclear. Therefore, we aimed to evaluate the significance of these glycemic indicators in early pregnancy for predicting GDM.</p><p><strong>Methods: </strong>This observational cohort study enrolled pregnant women who underwent initial prenatal examinations to determine their rBG, HbA1c, and GA levels at a rural maternity facility. Clinical data were retrospectively reviewed.</p><p><strong>Results: </strong>A total of 449 patients were analyzed, comprising 394 with normal glucose tolerance (NGT) and 55 with GDM. The rBG, HbA1c, and GA levels were significantly higher during early pregnancy in women who developed GDM than in those with NGT. Receiver operating characteristic curve analysis revealed that the areas under the curve (AUC) for rBG, HbA1c, and GA were 0.733, 0.591, and 0.608, respectively, with cutoff values of 100 mg/dL, 5.2%, and 14.6%, respectively. These cutoff values had sensitivities of 52.7%, 70.9%, and 36.4% and specificities of 87.6%, 43.4%, and 82.5%, respectively. The product of rBG and HbA1c levels demonstrated improved performance, with an AUC of 0.750, cutoff value of 509, 63.6% sensitivity, and 83.5% specificity.</p><p><strong>Conclusion: </strong>Glucose tolerance screening in early pregnancy using an rBG level of 100 mg/dL and an HbA1c level of 5.2% as cutoff values may help identify high-risk cases and enable early diagnosis of GDM.</p>","PeriodicalId":37602,"journal":{"name":"Obstetrics and Gynecology Science","volume":" ","pages":"273-282"},"PeriodicalIF":1.9,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12301561/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144508752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-06-11DOI: 10.5468/ogs.25009
Soo Jin Park, Sung Woo Kim, Sung Ah Kim, Hee Sun Kim, Jung-Won Choi, Moon-Joo Kang, Jung Yoon Choi, Hyoung Jin Kang, Hee Jin Son, Ji Yeon Han, Hoon Kim, Seung-Yup Ku
Objective: Fertility preservation is vital for adolescent and young adult (AYA) cancer patients. Sperm cryobanking is a key option, but age-related factors influencing its efficiency remain unclear. This study evaluated the impact of age on cryobanking attempts, success rates, and disposition outcomes among AYA patients with cancer aged 11-25 years.
Methods: We retrospectively analyzed 298 AYA patients with cancer referred for fertility preservation counseling over 9 years. Data on cryobanking attempts, success rates, and disposition outcomes were stratified by age group (11-15, 16-20, and 21-25 years). Logistic regression was used to assess factors influencing these outcomes.
Results: The mean age was 16.0 years, with leukemia (22.5%), sarcoma (22.1%), and lymphoma (17.1%) being the most common diagnoses. Among the cohort, 72.1% attempted cryobanking, with lower attempt rates in the youngest group (59.6%) compared to 82.2% and 88.2% in the older groups, respectively. Younger age was a significant predictor of not attempting cryobanking (adjusted odds ratio, 5.059; P=0.001); however, age did not affect the success of sperm cryobanking among patients who attempted it. Disposition analysis showed that 77.2% of samples remained in storage, while 16.2% were discarded; although disposal was often influenced by family decisions, no significant predictors of disposal were identified.
Conclusion: Younger patients are less likely to attempt sperm cryobanking, although success rates among those who do are comparable across age groups. While most patients continued storage, higher disposal rates in younger groups highlight the need for strategies to increase participation and support informed decision-making.
{"title":"Does a specific age group impact sperm cryobanking efficiency among adolescent and young adult cancer patients?","authors":"Soo Jin Park, Sung Woo Kim, Sung Ah Kim, Hee Sun Kim, Jung-Won Choi, Moon-Joo Kang, Jung Yoon Choi, Hyoung Jin Kang, Hee Jin Son, Ji Yeon Han, Hoon Kim, Seung-Yup Ku","doi":"10.5468/ogs.25009","DOIUrl":"10.5468/ogs.25009","url":null,"abstract":"<p><strong>Objective: </strong>Fertility preservation is vital for adolescent and young adult (AYA) cancer patients. Sperm cryobanking is a key option, but age-related factors influencing its efficiency remain unclear. This study evaluated the impact of age on cryobanking attempts, success rates, and disposition outcomes among AYA patients with cancer aged 11-25 years.</p><p><strong>Methods: </strong>We retrospectively analyzed 298 AYA patients with cancer referred for fertility preservation counseling over 9 years. Data on cryobanking attempts, success rates, and disposition outcomes were stratified by age group (11-15, 16-20, and 21-25 years). Logistic regression was used to assess factors influencing these outcomes.</p><p><strong>Results: </strong>The mean age was 16.0 years, with leukemia (22.5%), sarcoma (22.1%), and lymphoma (17.1%) being the most common diagnoses. Among the cohort, 72.1% attempted cryobanking, with lower attempt rates in the youngest group (59.6%) compared to 82.2% and 88.2% in the older groups, respectively. Younger age was a significant predictor of not attempting cryobanking (adjusted odds ratio, 5.059; P=0.001); however, age did not affect the success of sperm cryobanking among patients who attempted it. Disposition analysis showed that 77.2% of samples remained in storage, while 16.2% were discarded; although disposal was often influenced by family decisions, no significant predictors of disposal were identified.</p><p><strong>Conclusion: </strong>Younger patients are less likely to attempt sperm cryobanking, although success rates among those who do are comparable across age groups. While most patients continued storage, higher disposal rates in younger groups highlight the need for strategies to increase participation and support informed decision-making.</p>","PeriodicalId":37602,"journal":{"name":"Obstetrics and Gynecology Science","volume":" ","pages":"323-333"},"PeriodicalIF":1.9,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12301563/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Muhammad Ary Zucha, Dian Kesumapramudya Nurputra, Ardhanu Kusumanto, Shidiq Nur Hidayat, Kuwat Triyana, Widha Apriani Priadi, Nadia Yasmine, Ova Emilia
Objective: In this study, we developed a novel detection strategy based on volatile organic compound (VOC) sensing. Persistent infection by human papillomavirus (HPV) may cause biological changes in the cervical epithelium, leading to VOC production.
Methods: This study included 200 urine samples from cervical cancer patients and controls that were HPV-negative. Urine samples were collected and measured using a gas sensor array composed of a matrix of 10 sensors. For each analyzed sample, the instrument produced a vector signal encoding the VOC emitted from the urine (urine prints). The urine prints of cervical cancer patients were differentiated from those of healthy controls.
Results: Identification of VOC for cervical cancer detection showed reliable accuracy (91% sensitivity, 85% specificity, and 89% accuracy).
Conclusion: Our.
Results: demonstrated the applicability of VOC sensing for cervical cancer detection and its potential application in treatment monitoring.
{"title":"Identification of volatile organic compound as a novel modality for cervical cancer detection.","authors":"Muhammad Ary Zucha, Dian Kesumapramudya Nurputra, Ardhanu Kusumanto, Shidiq Nur Hidayat, Kuwat Triyana, Widha Apriani Priadi, Nadia Yasmine, Ova Emilia","doi":"10.5468/ogs.25038","DOIUrl":"10.5468/ogs.25038","url":null,"abstract":"<p><strong>Objective: </strong>In this study, we developed a novel detection strategy based on volatile organic compound (VOC) sensing. Persistent infection by human papillomavirus (HPV) may cause biological changes in the cervical epithelium, leading to VOC production.</p><p><strong>Methods: </strong>This study included 200 urine samples from cervical cancer patients and controls that were HPV-negative. Urine samples were collected and measured using a gas sensor array composed of a matrix of 10 sensors. For each analyzed sample, the instrument produced a vector signal encoding the VOC emitted from the urine (urine prints). The urine prints of cervical cancer patients were differentiated from those of healthy controls.</p><p><strong>Results: </strong>Identification of VOC for cervical cancer detection showed reliable accuracy (91% sensitivity, 85% specificity, and 89% accuracy).</p><p><strong>Conclusion: </strong>Our.</p><p><strong>Results: </strong>demonstrated the applicability of VOC sensing for cervical cancer detection and its potential application in treatment monitoring.</p>","PeriodicalId":37602,"journal":{"name":"Obstetrics and Gynecology Science","volume":" ","pages":"293-303"},"PeriodicalIF":1.9,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12301559/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144545211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-05-28DOI: 10.5468/ogs.24272
Ahmed Abu-Zaid, Ghadeer Adel Alghamdi, Alaa Saleh Alharbi, Saeed Baradwan, Saleh A K Saleh, Heba M Adly, Mooza M Alzayed, Mohammed Abuzaid, Raghad Sindi, Mohannad Alsabban, Osama Alomar
This systematic review and meta-analysis of randomized controlled trials (RCTs) assessed the effect of L-carnitine (LC) supplementation on the fertility outcomes of patients with polycystic ovary syndrome (PCOS). Online databases (Scopus, Web of Science, Cochrane Library, EMBASE, and PubMed) were searched to identify eligible RCTs published until March 2024. A dose-response meta-analysis was performed using a random-effects model. Meta-regression was also performed to investigate the source of heterogeneity based on the LC dose and duration of treatment. The pooled analysis included eight RCTs with 1,046 participants. The LC-treated group had significantly increased chemical and clinical pregnancy rates, ovulation rate, progesterone levels, number of preovulatory follicles >17 mm in diameter, and endometrial thickness compared to the untreated groups. The meta-analysis model indicated that LC supplementation did not change the serum levels of estrogen and testosterone; however, the dose-response meta-analysis indicated that prolonged LC intake significantly increased estrogen levels. LC supplementation has significant effects on fertility outcomes of women with PCOS. Additional large-scale longer RCTs are required to confirm the findings of this study.
本研究对随机对照试验(RCTs)进行了系统回顾和荟萃分析,评估了补充左旋肉碱(LC)对多囊卵巢综合征(PCOS)患者生育结局的影响。检索在线数据库(Scopus, Web of Science, Cochrane Library, EMBASE和PubMed)以确定在2024年3月之前发表的符合条件的rct。采用随机效应模型进行剂量-反应荟萃分析。我们还进行了meta回归来研究基于LC剂量和治疗持续时间的异质性来源。合并分析包括8项随机对照试验,共有1046名参与者。与未治疗组相比,lc治疗组的化学和临床妊娠率、排卵率、黄体酮水平、排卵前卵泡数量(直径17mm)和子宫内膜厚度均显著增加。meta分析模型显示,补充LC不会改变血清雌激素和睾酮水平;然而,剂量-反应荟萃分析显示,延长LC摄入可显著提高雌激素水平。补充LC对PCOS患者的生育结局有显著影响。需要更多的大规模、更长的随机对照试验来证实本研究的结果。
{"title":"Effect of L-carnitine supplementation on fertility outcomes among patients with polycystic ovary syndrome: a systematic review and dose-response meta-analysis of randomized clinical trials.","authors":"Ahmed Abu-Zaid, Ghadeer Adel Alghamdi, Alaa Saleh Alharbi, Saeed Baradwan, Saleh A K Saleh, Heba M Adly, Mooza M Alzayed, Mohammed Abuzaid, Raghad Sindi, Mohannad Alsabban, Osama Alomar","doi":"10.5468/ogs.24272","DOIUrl":"10.5468/ogs.24272","url":null,"abstract":"<p><p>This systematic review and meta-analysis of randomized controlled trials (RCTs) assessed the effect of L-carnitine (LC) supplementation on the fertility outcomes of patients with polycystic ovary syndrome (PCOS). Online databases (Scopus, Web of Science, Cochrane Library, EMBASE, and PubMed) were searched to identify eligible RCTs published until March 2024. A dose-response meta-analysis was performed using a random-effects model. Meta-regression was also performed to investigate the source of heterogeneity based on the LC dose and duration of treatment. The pooled analysis included eight RCTs with 1,046 participants. The LC-treated group had significantly increased chemical and clinical pregnancy rates, ovulation rate, progesterone levels, number of preovulatory follicles >17 mm in diameter, and endometrial thickness compared to the untreated groups. The meta-analysis model indicated that LC supplementation did not change the serum levels of estrogen and testosterone; however, the dose-response meta-analysis indicated that prolonged LC intake significantly increased estrogen levels. LC supplementation has significant effects on fertility outcomes of women with PCOS. Additional large-scale longer RCTs are required to confirm the findings of this study.</p>","PeriodicalId":37602,"journal":{"name":"Obstetrics and Gynecology Science","volume":" ","pages":"260-272"},"PeriodicalIF":1.9,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12301557/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144175159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: Placenta accreta spectrum (PAS) is a leading cause of massive obstetric hemorrhage, particularly when the placenta is removed or unintentionally disrupted during cesarean hysterectomy. In this video, we demonstrate an alternative surgical approach via the posterior vaginal fornix for performing cesarean hysterectomy in patients with PAS.
Methods: A cesarean hysterectomy for a case of placenta percreta was performed using the posterior vaginal fornix approach. This technique focuses on avoiding bleeding due to placental disruption and preventing urinary bladder injury.
Results: We summarize the steps of the procedure, including ligation of the vascular pedicles, entry into the retroperitoneal space to identify vital structures and control bleeding, dissection along avascular plane to delineate organ borders, and posterior culdotomy followed by en bloc uterine amputation to avoid urinary bladder injury and minimize blood loss.
Conclusion: The posterior vaginal fornix approach for cesarean hysterectomy in patients with PAS is an effective technique for minimizing bleeding from the highly vascular placental area. Additionally, it offers the advantage of reducing the risk of unintentional urinary bladder injury, thereby improving surgical outcomes in these challenging cases.
{"title":"Bleeding control and posterior vaginal fornix approach for cesarean hysterectomy in placenta accreta spectrum.","authors":"Thiti Atjimakul, Kulisara Nanthamongkolkul, Ingporn Jiamset, Yuthasak Suphasynth, Aroontorn Pichatechaiyoot, Ekasak Thiangphak, Chayut Pongpanich, Athithan Rattanaburi","doi":"10.5468/ogs.24216","DOIUrl":"10.5468/ogs.24216","url":null,"abstract":"<p><strong>Objective: </strong>Placenta accreta spectrum (PAS) is a leading cause of massive obstetric hemorrhage, particularly when the placenta is removed or unintentionally disrupted during cesarean hysterectomy. In this video, we demonstrate an alternative surgical approach via the posterior vaginal fornix for performing cesarean hysterectomy in patients with PAS.</p><p><strong>Methods: </strong>A cesarean hysterectomy for a case of placenta percreta was performed using the posterior vaginal fornix approach. This technique focuses on avoiding bleeding due to placental disruption and preventing urinary bladder injury.</p><p><strong>Results: </strong>We summarize the steps of the procedure, including ligation of the vascular pedicles, entry into the retroperitoneal space to identify vital structures and control bleeding, dissection along avascular plane to delineate organ borders, and posterior culdotomy followed by en bloc uterine amputation to avoid urinary bladder injury and minimize blood loss.</p><p><strong>Conclusion: </strong>The posterior vaginal fornix approach for cesarean hysterectomy in patients with PAS is an effective technique for minimizing bleeding from the highly vascular placental area. Additionally, it offers the advantage of reducing the risk of unintentional urinary bladder injury, thereby improving surgical outcomes in these challenging cases.</p>","PeriodicalId":37602,"journal":{"name":"Obstetrics and Gynecology Science","volume":" ","pages":"346-348"},"PeriodicalIF":1.9,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12301555/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144508751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-06-19DOI: 10.5468/ogs.25077
Wafaa M Kamal, Ahmed M Maged, Noha Salah, Nour A El-Goly, Wael El-Sherbiny, Elham S Hassan
Objective: This study aimed to evaluate the effects of narrowband ultraviolet B (UVB) irradiation on bone and muscle health in postmenopausal women.
Methods: A randomized controlled trial was conducted involving 70 postmenopausal women with vitamin D deficiency (<20 ng/mL) and osteopenia. Participants were randomly assigned to two groups. For 6 months, 35 postmenopausal women in study group A received three weekly sessions of narrowband UVB therapy and vitamin D supplements in the form of 100,000 international unit (IU) cholecalciferol weekly as loading therapy for 8 weeks. This was followed by the daily administration of cholecalciferol 3,000 IU as maintenance therapy for 16 weeks. The control group B consisted of 35 postmenopausal women who were administered vitamin D supplements alone for 6 months. Enzyme-linked immuno sorbent assay kits were used to test the serum levels of 25-hydroxyvitamin D (25(OH)D), dual-energy X-ray absorptiometry (DEXA) (DMS, Occitanie, France) was used to test the bone mineral density of the lumbar spine and right femur, and a Biodex System 3 (Biodex Medical Systems Inc., Shirley, NY, USA) isokinetic dynamometer was used to assess the peak torque of the extensors and flexors of the dominant knee.
Results: Serum 25(OH)D levels (P=0.000), Lumbar T-score (P=0.008), femoral T-score (P=0.002), and knee extensor peak torque (P=0.030) significantly increased in both groups after 6 months of treatment, favoring study group A over the control group B.
Conclusion: Narrowband UVB combined with vitamin D3 supplementation is more effective than vitamin D supplementation alone.
{"title":"Impact of ultraviolet radiation on bone density and muscle strength in postmenopausal women: a randomized controlled study.","authors":"Wafaa M Kamal, Ahmed M Maged, Noha Salah, Nour A El-Goly, Wael El-Sherbiny, Elham S Hassan","doi":"10.5468/ogs.25077","DOIUrl":"10.5468/ogs.25077","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate the effects of narrowband ultraviolet B (UVB) irradiation on bone and muscle health in postmenopausal women.</p><p><strong>Methods: </strong>A randomized controlled trial was conducted involving 70 postmenopausal women with vitamin D deficiency (<20 ng/mL) and osteopenia. Participants were randomly assigned to two groups. For 6 months, 35 postmenopausal women in study group A received three weekly sessions of narrowband UVB therapy and vitamin D supplements in the form of 100,000 international unit (IU) cholecalciferol weekly as loading therapy for 8 weeks. This was followed by the daily administration of cholecalciferol 3,000 IU as maintenance therapy for 16 weeks. The control group B consisted of 35 postmenopausal women who were administered vitamin D supplements alone for 6 months. Enzyme-linked immuno sorbent assay kits were used to test the serum levels of 25-hydroxyvitamin D (25(OH)D), dual-energy X-ray absorptiometry (DEXA) (DMS, Occitanie, France) was used to test the bone mineral density of the lumbar spine and right femur, and a Biodex System 3 (Biodex Medical Systems Inc., Shirley, NY, USA) isokinetic dynamometer was used to assess the peak torque of the extensors and flexors of the dominant knee.</p><p><strong>Results: </strong>Serum 25(OH)D levels (P=0.000), Lumbar T-score (P=0.008), femoral T-score (P=0.002), and knee extensor peak torque (P=0.030) significantly increased in both groups after 6 months of treatment, favoring study group A over the control group B.</p><p><strong>Conclusion: </strong>Narrowband UVB combined with vitamin D3 supplementation is more effective than vitamin D supplementation alone.</p>","PeriodicalId":37602,"journal":{"name":"Obstetrics and Gynecology Science","volume":" ","pages":"334-343"},"PeriodicalIF":1.9,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12301558/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144327151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-05-29DOI: 10.5468/ogs.25127
Noshaba Majeed, Shoaib Majeed, Jie Tu
{"title":"Methodological considerations and future directions for research on COVID-19 vaccination and menstrual changes.","authors":"Noshaba Majeed, Shoaib Majeed, Jie Tu","doi":"10.5468/ogs.25127","DOIUrl":"10.5468/ogs.25127","url":null,"abstract":"","PeriodicalId":37602,"journal":{"name":"Obstetrics and Gynecology Science","volume":" ","pages":"344-345"},"PeriodicalIF":1.9,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12301560/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144182663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}